Isotretinoin: reasserting its public health value at the population level, addressing potential neuropsychiatric risk at the individual level

Br J Dermatol. 2022 Nov;187(5):831-832. doi: 10.1111/bjd.21764. Epub 2022 Jul 31.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Dermatologic Agents* / adverse effects
  • Humans
  • Isotretinoin / adverse effects
  • Public Health

Substances

  • Isotretinoin
  • Dermatologic Agents